Work

“Clone-specific” antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers

Year: 2024

Type: article

Abstract: In a recent study published in Nature , Nichakawade et al. provided proof-of-principle data on innovative strategies to target and eliminate cancerous T-cells while sparing healthy T-lymphocytes, addressing the urgent clinical need posed by the mostly aggressive and treatment-refractory T-cell lymphomas. 1 This research represents a significant milestone in overcoming major obstacles in immunotherapies for these cancers.

Source: Signal Transduction and Targeted Therapy

DOI: 10.1038/s41392-024-01945-7

Authors: Dennis Jungherz, Philipp Lückemeier, Marco Herling

Institutions: University Hospital Leipzig, Leipzig University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,490